Stocks CILFY Financial statements
Financial statementsCHINA LIFE INSURANCE CO LTD financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data CHINA LIFE INSURANCE CO LTD files with the SEC in its annual reports.
In CNY millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2015 | FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 507,449 | 540,781 | 643,355 | 627,419 | 729,499 | 805,049 | 824,933 | 804,388 |
| General and administrative | 27,458 | 31,854 | 35,953 | 37,486 | 40,283 | 37,732 | 40,867 | 39,874 |
| Interest expense | 4,320 | 4,767 | 4,601 | 4,116 | 4,255 | 3,747 | 5,598 | 4,863 |
| Pre-tax income | 45,931 | 23,842 | 41,671 | 13,921 | 59,788 | 54,440 | 50,340 | 24,047 |
| Income tax | 10,744 | 4,257 | 8,919 | 1,985 | 781 | 3,103 | -1,917 | -9,467 |
| Net income to minority interests | 488 | 458 | 499 | 541 | 726 | 1,116 | 1,491 | 1,432 |
| Net income | 34,699 | 19,127 | 32,253 | 11,395 | 58,281 | 50,221 | 50,766 | 32,082 |
| EPS, basic | 1.22 | 0.66 | 1.13 | 0.39 | 2.05 | 1.77 | ||
| EPS, diluted | 1.22 | 0.66 | 1.13 | 0.39 | 2.05 | 1.77 |
Balance sheet
| FY2015 | FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 76,096 | 67,046 | 48,586 | 50,848 | 53,396 | 56,704 | 60,459 | 127,594 |
| Property, plant and equipment | 26,974 | 30,389 | 42,707 | 47,281 | 51,758 | 53,616 | 55,632 | 54,559 |
| Lease right-of-use assets | 2,555 | 3,520 | 3,076 | 2,518 | 1,810 | |||
| Total assets | 2,696,951 | 2,897,591 | 3,254,403 | 3,726,791 | 4,253,544 | 4,892,480 | 5,251,988 | |
| Total liabilities | 2,389,303 | 2,572,281 | 2,931,113 | 3,317,432 | 3,795,976 | 4,405,346 | 4,806,867 | |
| Retained earnings | 122,558 | 139,202 | 133,022 | 170,487 | 183,856 | 201,041 | 201,688 | |
| Shareholders' equity | 303,621 | 320,933 | 318,371 | 403,764 | 450,056 | 479,061 | 436,169 | |
| Minority interests | 4,027 | 4,377 | 4,919 | 5,578 | 6,881 | 8,073 | 8,952 | |
| Total equity | 326,214 | 307,648 | 325,310 | 320,426 | 410,027 | 457,568 | 487,134 | 445,121 |
| Total liabilities and equity | 2,696,951 | 2,897,591 | 3,254,403 | 3,726,734 | 4,252,466 | 4,892,480 | 5,251,988 |
Cash flow statement
| FY2015 | FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | |
|---|---|---|---|---|---|---|---|---|
| Net income | 35,187 | 19,585 | 32,752 | 11,936 | 59,007 | 51,337 | 52,257 | 33,514 |
| Depreciation and amortization | 2,036 | 2,083 | 2,240 | 2,638 | 4,379 | 5,164 | 5,328 | 5,291 |
| Cash from operations | -18,811 | 89,098 | 200,990 | 147,552 | 286,028 | 303,990 | 286,446 | 351,968 |
| Capital expenditures | -8,384 | -5,310 | -9,619 | -19,546 | -11,417 | -7,662 | -5,583 | -3,076 |
| Cash from investing | 67,047 | -104,703 | -173,676 | -238,373 | -247,517 | -292,992 | -393,839 | -164,955 |
| Debt issued | 0 | 13,831 | 3,121 | 727 | 123 | 7,036 | 116 | 688 |
| Debt repaid | 0 | -30,000 | -38,000 | -365 | -6,505 | -11 | -8,275 | |
| Cash from financing | -19,415 | 6,270 | -45,595 | 92,963 | -36,075 | -7,546 | 111,219 | -120,095 |
| Exchange rate effect | 241 | 285 | -179 | 81 | 55 | -144 | -71 | 217 |
| Net change in cash | 29,062 | -9,050 | -18,460 | 2,223 | 2,491 | 3,308 | 3,755 | 67,135 |
| Free cash flow | -27,195 | 83,788 | 191,371 | 128,006 | 274,611 | 296,328 | 280,863 | 348,892 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Pre-tax margin | 3.0% | Pre-tax income / revenue. |
| Net margin | 4.0% | Net income / revenue. |
| FCF margin | 43.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 43.8% | Cash from operations / revenue. |
| Effective tax rate | -39.4% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 7.0% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.6% | Net income / average total assets. |
| Capex / revenue | 0.4% | Capital expenditures / revenue. |
| D&A / revenue | 0.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -2.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 3.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 4.6% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -36.8% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -18.0% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -0.1% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 22.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 7.2% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 11.9% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 24.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 8.3% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 12.8% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -9.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 2.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 6.3% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 7.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 12.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 12.6% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Liabilities / assets | 91.5% | Total liabilities / total assets. |
| Tangible book value | CN¥436.17B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.16x | Revenue / average total assets. |
| Fixed asset turnover | 14.6x | Revenue / average property, plant and equipment. |
| FCF conversion | 1,088.0% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 0.9% | Capital expenditures / cash from operations, when that is positive. |
What was CHINA LIFE INSURANCE CO LTD's revenue in fiscal 2022?
CHINA LIFE INSURANCE CO LTD reported revenue of CN¥804.39B for fiscal 2022, 2.5% lower than the year before.
Was CHINA LIFE INSURANCE CO LTD profitable in fiscal 2022?
Yes. Net income was CN¥32.08B, a net margin of 4%.
How much free cash flow did CHINA LIFE INSURANCE CO LTD generate in fiscal 2022?
Cash from operations of CN¥351.97B minus capital expenditures of CN¥3.08B left free cash flow of CN¥348.89B.